Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Lindén

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
Rationale for targeting interleukin-17 in the lungsAnders Lindén
Pulmonary Pharmacology & Therapeutics|November 16, 2005
Interleukin-17 and airway remodellingAnders Lindén
Science'S STKE : Signal Transduction Knowledge Environment|August 9, 2007
A role for the cytoplasmic adaptor protein Act1 in mediating IL-17 signalingAnders Lindén
Trends in Pharmacological Sciences|January 24, 2009
Interleukin-17 as a drug target in human diseaseStefan Ivanov, Anders Lindén
The European Respiratory Journal|June 14, 2014
Interleukin-17 cytokine signalling in patients with asthmaAnders Lindén, Barbro Dahlén
Expert Review of Respiratory Medicine|May 19, 2010
Th-17 cells in the lungs?Stefan Ivanov, Anders Lindén
Expert Review of Respiratory Medicine|March 30, 2012
IL-17 in human asthmaElin Silverpil, Anders Lindén
Immunity|October 16, 2004
Interleukin-17 family members and inflammationJay K Kolls, Anders Lindén
Frontiers in Immunology|July 1, 2025
The role of T-helper and T regulatory cells in driving neutrophilic and eosinophilic inflammation in bronchiectasisEvangelia Fouka, Anders Lindén, Apostolos Bossios
Journal of Innate Immunity|July 24, 2015
Interleukin-26: An Emerging Player in Host Defense and InflammationSara Tengvall, Karlhans Fru Che, Anders Lindén
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
Rationale for targeting interleukin-17 in the lungsAnders Lindén
Pulmonary Pharmacology & Therapeutics|November 16, 2005
Interleukin-17 and airway remodellingAnders Lindén
Science'S STKE : Signal Transduction Knowledge Environment|August 9, 2007
A role for the cytoplasmic adaptor protein Act1 in mediating IL-17 signalingAnders Lindén
Trends in Pharmacological Sciences|January 24, 2009
Interleukin-17 as a drug target in human diseaseStefan Ivanov, Anders Lindén
The European Respiratory Journal|June 14, 2014
Interleukin-17 cytokine signalling in patients with asthmaAnders Lindén, Barbro Dahlén
Expert Review of Respiratory Medicine|May 19, 2010
Th-17 cells in the lungs?Stefan Ivanov, Anders Lindén
Expert Review of Respiratory Medicine|March 30, 2012
IL-17 in human asthmaElin Silverpil, Anders Lindén
Immunity|October 16, 2004
Interleukin-17 family members and inflammationJay K Kolls, Anders Lindén
Frontiers in Immunology|July 1, 2025
The role of T-helper and T regulatory cells in driving neutrophilic and eosinophilic inflammation in bronchiectasisEvangelia Fouka, Anders Lindén, Apostolos Bossios
Journal of Innate Immunity|July 24, 2015
Interleukin-26: An Emerging Player in Host Defense and InflammationSara Tengvall, Karlhans Fru Che, Anders Lindén
Pageof 9